Company / Current Assets
FENNEC PHARMACEUTICALS INC. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$67.0M
FY2025
5-year range
$13.9M / $67.0M
FY2021-FY2025
Trend
+51.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 4 consecutive years, from $14M in FY2019 to $67M in FY2025.
Based on SEC 10-K filings.
$67M in FY2025.
Improved from $27M to $67M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- FENNEC PHARMACEUTICALS INC.'s current assets has grown for 4 consecutive years.
- In FY2025, current assets increased 51.9% year-over-year.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.0M | +51.9% |
| FY2024 | $44.1M | +64.3% |
| FY2023 | $26.9M | +20.0% |
| FY2021 | $22.4M | +61.2% |
| FY2019 | $13.9M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026